Target haematocrit during erythropoietin therapy

Nephrology Dialysis Transplantation

Volumn 12, Issue 9, 1997, Pages 1813-1816

  Nissenson, A R ^a   Besarab, A ^a   Bolton, W K ^a   Goodkin, D A ^a   Schwab, S J ^a  

^a UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN;

BRAIN FUNCTION; CARDIOVASCULAR FUNCTION; CLINICAL TRIAL; EXERCISE; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; META ANALYSIS; MUSCLE FUNCTION; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT SURVEY; VASCULAR ACCESS;

CARDIOVASCULAR SYSTEM; CATHETERS, INDWELLING; ERYTHROPOIETIN; HEMATOCRIT; HUMANS; KIDNEY FAILURE, CHRONIC; PHYSICAL ENDURANCE; QUALITY OF LIFE; RECOMBINANT PROTEINS; THROMBOSIS;

EID: 0030758805     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.9.1813     Document Type: Short Survey

References (30)